Literature DB >> 9177975

A critical appraisal of current management practices for infant regurgitation--recommendations of a working party.

Y Vandenplas1, D Belli, P Benhamou, S Cadranel, J P Cezard, S Cucchiara, C Dupont, C Faure, F Gottrand, E Hassall, H Heymans, C M Kneepkens, B Sandhu.   

Abstract

Regurgitation is a common manifestation in infants below the age of 1 year and a frequent reason of counselling of general practitioners and paediatricians. Current management starts with postural and dietary measures, followed by antacids and prokinetics. Recent issues such as an increased risk of sudden infant death in the prone sleeping position and persistent occult gastro-oesophageal reflux in a subset of infants receiving milk thickeners or thickened "anti-regurgitation formula" challenge the established approach. Therefore, the clinical practices for management of infant regurgitation have been critically evaluated with respect to their efficacy, safety and practical implications. The updated recommendations reached by the working party on the management of infant regurgitation contain five phases: (1 A) parental reassurance; (1 B) milk-thickening agents; (2) prokinetics; (3) positional therapy as an adjuvant therapy; (4 A) H2-blockers; (4 B) proton pump inhibitors; (5) surgery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9177975     DOI: 10.1007/s004310050613

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  Diagnosis and treatment of gastroesophageal reflux disease in infants and children.

Authors:  Yvan Vandenplas
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

Review 2.  Infant food applications of complex carbohydrates: Structure, synthesis, and function.

Authors:  Dorothy L Ackerman; Kelly M Craft; Steven D Townsend
Journal:  Carbohydr Res       Date:  2016-11-11       Impact factor: 2.104

Review 3.  Gastroesophageal reflux in infants and children. When to reassure and when to go further.

Authors:  A B Jones
Journal:  Can Fam Physician       Date:  2001-10       Impact factor: 3.275

Review 4.  Efficacy and tolerability of cisapride in children.

Authors:  Y Vandenplas; A Benatar; F Cools; A Arana; B Hegar; B Hauser
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 5.  Validation issues in questionnaires for diagnosis and monitoring of gastroesophageal reflux disease in children.

Authors:  Leah Kleinman; Dennis A Revicki; Emuella Flood
Journal:  Curr Gastroenterol Rep       Date:  2006-06

Review 6.  Gastroesophageal reflux disease in children with asthma: treatment implications.

Authors:  Mark D Scarupa; Nanako Mori; Brendan J Canning
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

7.  Use of Gastroesophageal Reflux Medications in Premature Infants After NICU Discharge.

Authors:  Jo Ann D'Agostino; Molly Passarella; Ashley E Martin; Scott A Lorch
Journal:  Pediatrics       Date:  2016-12       Impact factor: 7.124

Review 8.  GORD in children.

Authors:  Yadlapalli Kumar; Rajini Sarvananthan
Journal:  BMJ Clin Evid       Date:  2008-10-01

9.  Extrapolation of Efficacy in Pediatric Drug Development and Evidence-based Medicine: Progress and Lessons Learned.

Authors:  Haihao Sun; Jean W Temeck; Wiley Chambers; Ginger Perkins; Renan Bonnel; Dianne Murphy
Journal:  Ther Innov Regul Sci       Date:  2017-08-18       Impact factor: 1.778

10.  An antiregurgitation milk formula in the management of infants with mild to moderate gastroesophageal reflux.

Authors:  Ioannis Xinias; Kleomenis Spiroglou; Vasiliki Demertzidou; Eliza Karatza; Christos Panteliadis
Journal:  Curr Ther Res Clin Exp       Date:  2003-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.